Digital Health
Instacart confidentially filed for an initial public offering with the Securities and Exchange Commission earlier this year.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
The JMIR study found themes like cost, functionality, progress tracking and educational content were important to consumers.
Leslie Witt, Headspace Health's chief product and design officer, explains how the company's acquisitions are augmenting its mental health offerings and capabilities.
Also, digital health company RaphaCure has launched its mobile corporate wellness app.
The company will use the funding to support the commercial expansion of its product.
The insurer said the new offering will be included in the majority of its commercial health plans.
The startup plans to use the capital to improve the platform so larger health systems and organizations can use its tools at scale.